Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited (SGX:T14)
Singapore
· Delayed Price · Currency is SGD · Price in USD 3.210
+0.050 (1.58%)
Apr 28, 2026, 5:04 PM SGT
47.25% (1Y)
| Market Cap | 5.06B |
| Revenue (ttm) | 904.27M |
| Net Income (ttm) | 391.88M |
| Shares Out | n/a |
| EPS (ttm) | 0.51 |
| PE Ratio | 12.92 |
| Forward PE | n/a |
| Dividend | 0.67 (21.01%) |
| Ex-Dividend Date | Jan 30, 2026 |
| Volume | 166,900 |
| Average Volume | 171,100 |
| Open | 3.170 |
| Previous Close | 3.160 |
| Day's Range | 3.170 - 3.210 |
| 52-Week Range | 2.150 - 3.750 |
| Beta | n/a |
| RSI | 47.80 |
| Earnings Date | Mar 31, 2026 |